Another case of pediatric cecal diverticulitis

Barrie S. Rich,E. Cheng,L. Cohen,Calvin Sy,N. Spigland

DOI: https://doi.org/10.1007/s00383-012-3180-9

2012-09-30

Abstract:

What problem does this paper attempt to address?

Cue reactivity in nicotine and tobacco dependence: a “multiple-action” model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli

C. Chiamulera

DOI: https://doi.org/10.1016/j.brainresrev.2004.08.005

2005-02-01

Brain Research Reviews

Abstract:
Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Weihua Gong,Baoqing Liu,Juntao Chen,Chen Liu,Zhonghua Shen

DOI: https://doi.org/10.12659/aot.907598

2018-01-01

Annals of Transplantation

Abstract:BACKGROUND Although our previous studies revealed the role of Tregs (regulatory T cells) and MDSCs (myeloid-derived suppressor cells) in a pre-sensitized cardiac transplant model, interplay between Tregs and NK cells, neutrophils, and macrophages remain undefined. MATERIAL AND METHODS Mice heart transplantation with skin pre-sensitization was performed, in which prolonged-cold ischemia time (PCI) was used for donor treatment. Syngeneic heterotopic heart transplant recipients with PCI were treated with PC61 (monoclonal anti-CD25 antibodies), adoptive cell transfer with Tregs, and rapamycin. RESULTS We unveiled that both rapamycin treatment and adoptive transfer of Tregs could lead to a remarkable decrease of frequency of splenic Gr1+ cells (P=0.058 and P=0.016, respectively). Although administration of PC61 did not affect frequency of splenic Gr1+ cells, it dramatically increased frequency of splenic F4/80+ macrophages (P=0.052). Intriguingly, use of both exogenous PC61 and rapamycin induced a dramatic augmentation of frequency of Gr-1+ neutrophils in the grafts (PC61: P=0.00029; rapamycin: P=0.0096). Noticeably, all different regimens including PC61, rapamycin, and adoptive transfer of Tregs, consistently resulted in a remarked augmentation of frequency of F4/80+ macrophages within grafts (PC61, P=0.0013; rapamycin, P=0.015; Tregs transfer, P=0.013). Although rapamycin and adoptive transfer of Tregs did not affect frequency of NK1.1+ cells, administration of PC61 dramatically increased frequency of NK1.1+ cells within grafts (P=0.033). CONCLUSIONS Tregs depletion or Tregs induced by rapamycin or exogenous cell transfer could affect frequencies of both splenic and intragraft neutrophils, macrophages, and NK cells, but not splenic NK cells. Our data might shed light on understanding sensitized transplant biology.
Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Weidong Li,Dimin Wang,Rongcai Yue,Xin Chen,Aixia Liu,Hongfei Xu,Peng Teng,Zhen Wang,Yu Zou,Xingjie Xu,Haige Zhao,Renyuan Li,Yufei Fu,Lei Guo,Chengyao Ni,Jingya Fan,Liang Ma

DOI: https://doi.org/10.1016/j.healun.2021.08.008

IF: 13.569

2021-01-01

The Journal of Heart and Lung Transplantation

Abstract:BACKGROUND: Regulatory B cells (Bregs) play an important role in maintaining immune homeostasis and have the potential to induce tolerance. Previous work has found that Breg cells are involved in heart transplantation tolerance. However, the effect of Breg on the transplantation tolerance and the underlying mechanisms remain to be clarified. METHODS: Using a within-species heart transplantation model, we aimed to investigate the role of CD19(+) CD5(+) CD1d(high) Bregs isolated from transplanted mice in preventing transplant rejection in vivo. We also explored the effects of CD40 and tumor necrosis factor receptor-associated factor 6 (TRAF6) ubiquitin ligase on Breg-mediated prolongation of survival in heart transplant (HT) mice, and the regulatory effects of downstream Cdk4 and Cdk6 proteins on dendritic cells (DCs), which clarified the function and molecular mechanism of Breg cells in HT mice. RESULTS: Our data suggest that adoptive transfer of the transplanted Bregs served as an effective tolerance-inducing mechanism in HT mice and was involved in the CD40-TRAF6 signaling pathway in DCs. Moreover, DCs collected from the Breg treated HT mice also prolonged the survival of HT mice. Furthermore, DC-specific knockout of TRAF6 diminished Breg-mediated prolongation of survival in HT mice. Interestingly, gut microbes from donors increased the survival of cardiac allografts both in both the absence and presence of Bregs but were not implicated in CD40-TRAF6 signaling. CONCLUSIONS: These findings reveal a role of Breg cells in the induction of transplantation tolerance through the blockade of the CD40-TRAF6 signaling pathway, which might be used in the treatment of HT in the clinic. (C) 2021 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.
Fibroblastic reticular cells orchestrate long-term graft survival following recipient treatment with CD40 ligand-targeted costimulatory blockade

Robert L Fairchild

DOI: https://doi.org/10.1172/JCI165174

2022-12-15

Abstract:Fibroblastic reticular cells (FRCs) maintain the architecture of secondary lymphoid organs, which optimize interactions between antigen-presenting dendritic cells and reactive naive T cells. In this issue of the JCI, Zhao, Jung, and colleagues investigated CD4+FoxP3+ regulatory T cell development and long-term heart allograft survival in recipients treated with peritransplant costimulatory blockade to inhibit CD40/CD40 ligand (CD40L) signaling. Treatment with an anti-CD40L monoclonal antibody (mAb) increased the lymph node (LN) population of Madcam1+ FRCs and altered their transcription profile to express immunoregulatory mediators. Administration of nanoparticles, containing the anti-CD40L mAb and a targeting antibody against high endothelial venules, delivered the treatment into LNs of allograft recipients. Direct LN delivery of the costimulatory blockade allowed decreased dosing and increased the efficacy in extending graft survival. The results provide insights into mechanisms by which FRCs can promote donor-reactive tolerance, and establish a strategy for administering costimulation-blocking reagents that circumvent systemic effects and improve allograft outcomes.
Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.

Weihua Gong,Fangmin Ge,Dahai Liu,Yan Wu,Fangbing Liu,Beom Seok Kim,Tao Huang,Maria Koulmanda,Simon C Robson,Terry B Strom

DOI: https://doi.org/10.1016/j.clim.2014.03.013

2014-01-01

Abstract:Harness of sensitized transplantation remains a clinical challenge particularly in parallel with prolonged cold ischemia time (PCI)-mediated injury. Our present study was to test the role of myeloid-derived suppressor cells (MDSCs) in mouse pre-sensitized transplantation. Our findings revealed that CD11b+Gr1(low) MDSC was shown to have strong suppressive activity. MDSCs subsets from the tolerated mice exhibited higher suppressive capacities compared with counterparts from naive (untreated) mice. Depletion of Tregs could not affect splenic CD11b+Gr1(-low) MDSC frequency, but increase peripheral and intragraft CD11b+Gr1(-low) frequency. Intriguingly, boost of Tregs remarkably caused an increase of CD11b+Gr1(-low) frequency in the graft, peripheral blood, and spleen. Furthermore, peripheral CD11b+Gr1(-low) cells were massively accumulated at the early stage when allogeneic immune response was enhanced. Taken together, MDSCs could prevent grafts from PCI-mediated injury independent on Tregs in the pre-sensitized transplant recipients. Utilization of MDSC subset particularly CD11b+Gr1(-low) might provide a novel insight into improving graft outcome under such clinical scenarios.
Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice

Jing Zhao,Sungwook Jung,Xiaofei Li,Lushen Li,Vivek Kasinath,Hengcheng Zhang,Said N. Movahedi,Ahmad Mardini,Gianmarco Sabiu,Yoonha Hwang,Vikas Saxena,Yang Song,Bing Ma,Sophie E. Acton,Pilhan Kim,Joren C. Madsen,Peter T. Sage,Stefan G. Tullius,George C. Tsokos,Jonathan S. Bromberg,Reza Abdi

DOI: https://doi.org/10.1172/jci159672

IF: 19.456

2022-12-16

Journal of Clinical Investigation

Abstract:The lymph node (LN) is the primary site of alloimmunity activation and regulation during transplantation. Here, we investigated how fibroblastic reticular cells (FRCs) facilitate the tolerance induced by anti-CD40L in a murine model of heart transplantation. We found that both the absence of LNs and FRC depletion abrogated the effect of anti-CD40L in prolonging murine heart allograft survival. Depletion of FRCs impaired homing of T cells across the high endothelial venules (HEVs) and promoted formation of alloreactive T cells in the LNs in heart-transplanted mice treated with anti-CD40L. Single-cell RNA sequencing of the LNs showed that anti-CD40L promotes a Madcam1 + FRC subset. FRCs also promoted the formation of regulatory T cells (Tregs) in vitro. Nanoparticles (NPs) containing anti-CD40L were selectively delivered to the LNs by coating them with MECA-79, which binds to peripheral node addressin (PNAd) glycoproteins expressed exclusively by HEVs. Treatment with these MECA-79–anti-CD40L-NPs markedly delayed the onset of heart allograft rejection and increased the presence of Tregs. Finally, combined MECA-79–anti-CD40L-NPs and rapamycin treatment resulted in markedly longer allograft survival than soluble anti-CD40L and rapamycin. These data demonstrate that FRCs are critical to facilitating costimulatory blockade. LN-targeted nanodelivery of anti-CD40L could effectively promote heart allograft acceptance.

medicine, research & experimental
FRC transplantation restores lymph node conduit defects in laminin α4–deficient mice

Lushen Li,Long Wu,Allison Kensiski,Jing Zhao,Marina W. Shirkey,Yang Song,Wenji Piao,Tianshu Zhang,Zhongcheng Mei,Samuel J. Gavzy,Bing Ma,Vikas Saxena,Young S. Lee,Yanbao Xiong,Xiaofei Li,Xiaoxuan Fan,Reza Abdi,Jonathan S. Bromberg

DOI: https://doi.org/10.1172/jci.insight.167816

IF: 9.4958

2023-04-25

JCI Insight

Abstract:Fibroblastic reticular cells (FRCs) play important roles in tolerance by producing laminin α4 (Lama4) and altering lymph node (LN) structure and function. The present study revealed the specific roles of extracellular matrix Lama4 in regulating LN conduits using FRC-specific KO mouse strains. FRC-derived Lama4 maintained conduit fiber integrity, as its depletion altered conduit morphology and structure and reduced homeostatic conduit flow. Lama4 regulated the lymphotoxin β receptor (LTβR) pathway, which is critical for conduit and LN integrity. Depleting LTβR in FRCs further reduced conduits and impaired reticular fibers. Lama4 was indispensable for FRC generation and survival, as FRCs lacking Lama4 displayed reduced proliferation but upregulated senescence and apoptosis. During acute immunization, FRC Lama4 deficiency increased antigen flow through conduits. Importantly, adoptive transfer of WT FRCs to FRC Lama4–deficient mice rescued conduit structure, ameliorated Treg and chemokine distribution, and restored transplant allograft acceptance, which were all impaired by FRC Lama4 depletion. Single-cell RNA sequencing analysis of LN stromal cells indicated that the laminin and collagen signaling pathways linked crosstalk among FRC subsets and endothelial cells. This study demonstrated that FRC Lama4 is responsible for maintaining conduits by FRCs and can be harnessed to potentiate FRC-based immunomodulation.

medicine, research & experimental
Fibroblastic reticular cells provide a supportive niche for lymph node-resident macrophages

Joshua D'Rozario,Konstantin Knoblich,Mechthild Lütge,Christian Pérez Shibayama,Hung-Wei Cheng,Yannick O Alexandre,David Roberts,Joana Campos,Emma E Dutton,Muath Suliman,Alice E Denton,Shannon J Turley,Richard L Boyd,Scott N Mueller,Burkhard Ludewig,Tracy S P Heng,Anne L Fletcher

DOI: https://doi.org/10.1002/eji.202250355

Abstract:The lymph node (LN) is home to resident macrophage populations that are essential for immune function and homeostasis, but key factors controlling this niche are undefined. Here, we show that fibroblastic reticular cells (FRCs) are an essential component of the LN macrophage niche. Genetic ablation of FRCs caused rapid loss of macrophages and monocytes from LNs across two in vivo models. Macrophages co-localized with FRCs in human LNs, and murine single-cell RNA-sequencing revealed that FRC subsets broadly expressed master macrophage regulator CSF1. Functional assays containing purified FRCs and monocytes showed that CSF1R signaling was sufficient to support macrophage development. These effects were conserved between mouse and human systems. These data indicate an important role for FRCs in maintaining the LN parenchymal macrophage niche.
Helper T Cell (CD4 + ) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity

Jia Shen,Chang Liu,Pengpeng Yan,Meifang Wang,Luying Guo,Shuaihui Liu,Jianghua Chen,Jessica M. Rosenholm,Hongfeng Huang,Rending Wang,Hongbo Zhang

DOI: https://doi.org/10.34133/2022/9794235

2022-01-01

Abstract:Antibody-mediated rejection (ABMR) is a major cause of dysfunction and loss of transplanted kidney. The current treatments for ABMR involve nonspecific inhibition and clearance of T/B cells or plasma cells. However, the prognosis of patients following current treatment is poor. T follicular helper cells (Tfh) play an important role in allograft-specific antibodies secreting plasma cell (PC) development. Tfh cells are therefore considered to be important therapeutic targets for the treatment of antibody hypersecretion disorders, such as transplant rejection and autoimmune diseases. Tacrolimus (Tac), the primary immunosuppressant, prevents rejection by reducing T cell activation. However, its administration should be closely monitored to avoid serious side effects. In this study, we investigated whether Tac delivery to helper T (CD4 + ) cells using functionalized mesoporous nanoparticles can block Tfh cell differentiation after alloantigen exposure. Results showed that Tac delivery ameliorated humoral rejection injury in rodent kidney graft by suppressing Tfh cell development, PC, and donor-specific antibody (DSA) generation without causing severe side effects compared with delivery through the drug administration pathway. This study provides a promising therapeutic strategy for preventing humoral rejection in solid organ transplantation. The specific and controllable drug delivery avoids multiple disorder risks and side effects observed in currently used clinical approaches.
L-selectin-dependent Lymphoid Occupancy is Required to Induce Alloantigen-Specific Tolerance.

YL Bai,JH Liu,YN Wang,S Honig,LH Qin,P Boros,JS Bromberg

DOI: https://doi.org/10.4049/jimmunol.168.4.1579

2002-01-01

Abstract:Maneuvers that interfere with signals 1, 2, 3, or Ag processing can result in indefinite allograft survival. However, they are not applicable to all tissues, strains, or species, suggesting that there are additional levels of immune regulation. We hypothesized that secondary lymphoid organs are important for interactions among lymphocytes, alloantigen, and immunosuppressants that lead to tolerance. To explore this, cardiac allografts were performed with a tolerogenic immunosuppressive regimen. Concurrent administration of anti-L-selectin (CD62L) Ab, which prevents lymph node homing, prevents indefinite allograft survival and tolerance. Anti-CD62L Ab is not costimulatory, and Fab and F(ab')(2) anti-CD62L have similar activities. Flow cytometry and histologic examination show that Ab shifts T cells away from lymph nodes and into spleen, peripheral blood, and graft. Tolerance is not induced in CD62L(-/-) mice, and adoptive transfer of CD62L(-/-), but not CD62L(+/+), T cells prevents tolerization in wild-type recipients. FTY720, an immunosuppressant that promotes chemokine-dependent, but CD62L-independent, lymph node homing, reverses the Ab effect. Blockade of other homing receptors also prevents tolerization. These results indicate that T lymphocytes use CD62L-dependent migration for alloantigen-specific tolerance, and suggest that lymph nodes or other lymphoid tissues are an important site for peripheral tolerization to alloantigen.
Human lymph node fibroblastic reticular cells maintain heterogeneous characteristics in culture

Janna E G Roet,Andrew I Morrison,Aleksandra M Mikula,Michael de Kok,Daphne Panocha,Henk P Roest,Luc J W van der Laan,Charlotte M de Winde,Reina E Mebius

DOI: https://doi.org/10.1016/j.isci.2024.110179

IF: 5.8

2024-06-04

iScience

Abstract:Fibroblastic reticular cells (FRCs) are mesenchymal stromal cells in human lymph nodes (LNs) playing a pivotal role in adaptive immunity. Several FRC subsets have been identified, yet it remains to be elucidated if their heterogeneity is maintained upon culture. Here, we established a protocol to preserve and culture FRCs from human LNs and characterized their phenotypic profile in fresh LN suspensions and upon culture using multispectral flow cytometry. We found nine FRC subsets in fresh human LNs, independent of donor, of which four persisted in culture throughout several passages. Interestingly, the historically FRC-defining marker podoplanin (PDPN) was not present on all FRC subsets. Therefore, we propose that CD45negCD31neg human FRCs are not restricted by PDPN expression, as we found CD90, BST1, and CD146/MCAM to be more widely expressed. Together, our data provide insight into FRC heterogeneity in human LNs, enabling further investigation into the function of individual FRC subsets.
TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression

Peng Cao,Zejia Sun,Feilong Zhang,Jiandong Zhang,Xiang Zheng,Baozhong Yu,Yong Zhao,Wei Wang,Wei Wang

DOI: https://doi.org/10.3389/fimmu.2022.919674

IF: 7.3

2022-07-08

Frontiers in Immunology

Abstract:Myeloid-derived suppressor cells (MDSCs) are a class of heterogeneous myeloid cells, which play an important role in immunosuppression. We intended to find an effective method that can produce MDSCs with significantly better efficiency and promote immune tolerance for transplant rejection through cell therapy. It has been reported that granulocyte and macrophage colony-stimulating factor (GM-CSF) could induce MDSCs in vitro to cause immunosuppression. In the present study, transforming growth factor β (TGF-β) was added to the induction system, and flow cytometry analysis was used to detect the phenotypes of induced MDSCs. Their potential immunosuppressive function and mechanisms were determined by co-culturing MDSCs with stimulated T cells in vitro and transferring MDSCs to the skin grafted C57BL/6J mouse models in vivo . It was found that the addition of TGF-β could effectively cause bone marrow cells to differentiate into a group of cells with stronger immunosuppressive functions, thereby inhibiting the proliferation of stimulated T cells. The population of CD11b + Gr-1 + MDSCs also increased significantly as compared with GM-CSF alone treatment. While detecting for immunosuppressive effectors, we found that expression of arginase 1 (Arg-1) was significantly upregulated in these MDSCs, and inhibitor of Arg-1 significantly suppressed their immunosuppressive capabilities. Moreover, an adoptive transfer of these cells significantly prolonged survival of allo-skin and improved immune tolerance in vivo . These findings indicated that TGF-β + GM-CSF could serve as an effective and feasible method to induce powerful immunosuppressive MDSCs in vitro . Thus, TGF-β + GM-CSF–induced MDSCs may have a promising role in prevention of the graft rejection.

immunology
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Benedetta Apollonio,Filomena Spada,Nedyalko Petrov,Domenico Cozzetto,Despoina Papazoglou,Peter Jarvis,Shichina Kannambath,Manuela Terranova-Barberio,Rose-Marie Amini,Gunilla Enblad,Charlotte Graham,Reuben Benjamin,Elisabeth Phillips,Richard Ellis,Rosamond Nuamah,Mansoor Saqi,Dinis P Calado,Richard Rosenquist,Lesley A Sutton,Jon Salisbury,Georgios Zacharioudakis,Anna Vardi,Patrick R Hagner,Anita K Gandhi,Marina Bacac,Christina Claus,Pablo Umana,Ruth F Jarrett,Christian Klein,Alexander Deutsch,Alan G Ramsay

DOI: https://doi.org/10.1172/JCI166070

2023-07-03

Abstract:Recent transcriptomic-based analysis of diffuse large B cell lymphoma (DLBCL) has highlighted the clinical relevance of LN fibroblast and tumor-infiltrating lymphocyte (TIL) signatures within the tumor microenvironment (TME). However, the immunomodulatory role of fibroblasts in lymphoma remains unclear. Here, by studying human and mouse DLBCL-LNs, we identified the presence of an aberrantly remodeled fibroblastic reticular cell (FRC) network expressing elevated fibroblast-activated protein (FAP). RNA-Seq analyses revealed that exposure to DLBCL reprogrammed key immunoregulatory pathways in FRCs, including a switch from homeostatic to inflammatory chemokine expression and elevated antigen-presentation molecules. Functional assays showed that DLBCL-activated FRCs (DLBCL-FRCs) hindered optimal TIL and chimeric antigen receptor (CAR) T cell migration. Moreover, DLBCL-FRCs inhibited CD8+ TIL cytotoxicity in an antigen-specific manner. Notably, the interrogation of patient LNs with imaging mass cytometry identified distinct environments differing in their CD8+ TIL-FRC composition and spatial organization that associated with survival outcomes. We further demonstrated the potential to target inhibitory FRCs to rejuvenate interacting TILs. Cotreating organotypic cultures with FAP-targeted immunostimulatory drugs and a bispecific antibody (glofitamab) augmented antilymphoma TIL cytotoxicity. Our study reveals an immunosuppressive role of FRCs in DLBCL, with implications for immune evasion, disease pathogenesis, and optimizing immunotherapy for patients.
Metabolic Reprogramming of Fibroblastic Reticular Cells in Immunity and Tolerance

Dejun Kong,Marina WillsonShirkey,Wenji Piao,Long Wu,Shunqun Luo,Allision Kensiski,Jing Zhao,Young Lee,Reza Abdi,Hong Zheng,Jonathan S. Bromberg

DOI: https://doi.org/10.1002/eji.202451321

2024-11-24

European Journal of Immunology

Abstract:This review addresses how fibroblastic reticular cells (FRCs) undergo metabolic reprogramming in response to infections, autoimmune diseases, and cancer, adjusting their glycolysis, oxidative phosphorylation, and fatty acid metabolism to modulate immune functions. These metabolic shifts in FRCs highlight potential therapeutic strategies to improve immune regulation across various disease contexts. Fibroblastic reticular cells (FRCs) are pivotal stromal components that maintain the structure of secondary lymphoid tissues and modulate the immune responses within the lymphoid microenvironment. In response to specific immune or inflammatory stimuli, such as infection or autoimmune triggers, FRCs undergo significant metabolic reprogramming. This process, originally characterized in cancer research, involves the regulation of key metabolic enzymes, pathways, and metabolites, resulting in functional transformations of these cells. Specifically, viruses stimulate FRCs to enhance the tricarboxylic acid cycle, while rheumatoid arthritis and sepsis prompt FRCs to increase oxidative phosphorylation. These changes enable FRCs to adapt their functions, such as proliferation or cytokine secretion, thereby effectively regulating the immune microenvironment to meet the dynamic needs of the immune system. This review provides a comprehensive update on the metabolic reprogramming of FRCs, highlighting how these changes support immune tolerance and response under varied physiological conditions.

immunology
[Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].

C. Aguirre,F. Haramburu

1995-11-01

Abstract:This report compares the drug surveillance systems in France and Spain. The Spanish causality assessment method is explained. The Spanish and French drug surveillance systems are rather similar, but with some variations in the data analysis and differences between causality algorithms used. Spontaneous reporting in two drug surveillance centres, Aquitaine (Bordeaux, France) and in the Spanish Basque Country (SBC) (type of reports, reporting form) is compared. Reports received by the two centres during the year 1992 are presented. The SBC Centre has received more reports and differences in the source and type of effects were observed.
Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.

S. Okuyama,H. Mishina

1985-12-01

Abstract:
Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance

Yuanfei Zhao,Leigh Nicholson,Hannah Wang,Yi Wen Qian,Wayne J Hawthorne,Elvira Jimenez-Vera,Brian S Gloss,Joey Lai,Adwin Thomas,Yi Vee Chew,Heather Burns,Geoff Y Zhang,Yuan Min Wang,Natasha M Rogers,Guoping Zheng,Shounan Yi,Stephen I Alexander,Philip J O'Connell,Min Hu

DOI: https://doi.org/10.1172/jci.insight.169119

IF: 9.4958

2024-02-13

JCI Insight

Abstract:CD4+Foxp3+ regulatory T cells (Tregs) play an essential role in suppressing transplant rejection, but their role within the graft and heterogeneity in tolerance are poorly understood. Here, we compared phenotypic and transcriptomic characteristics of Treg populations within lymphoid organs and grafts in an islet xenotransplant model of tolerance. We showed Tregs were essential for tolerance induction and maintenance. Tregs demonstrated heterogeneity within the graft and lymphoid organs of tolerant mice. A subpopulation of CD127hi Tregs with memory features were found in lymphoid organs, presented in high proportions within long-surviving islet grafts, and had a transcriptomic and phenotypic profile similar to tissue Tregs. Importantly, these memory-like CD127hi Tregs were better able to prevent rejection by effector T cells, after adoptive transfer into secondary Rag-/- hosts, than naive Tregs or unselected Tregs from tolerant mice. Administration of IL-7 to the CD127hi Treg subset was associated with a strong activation of phosphorylation of STAT5. We proposed that memory-like CD127hi Tregs developed within the draining lymph node and underwent further genetic reprogramming within the graft toward a phenotype that had shared characteristics with other tissue or tumor Tregs. These findings suggested that engineering Tregs with these characteristics either in vivo or for adoptive transfer could enhance transplant tolerance.
Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen

David A. Horwitz,Ju Hua Wang,Dongin Kim,Chang Kang,Katja Brion,Sean Bickerton,Antonio La Cava

DOI: https://doi.org/10.3389/fimmu.2024.1429335

IF: 7.3

2024-07-26

Frontiers in Immunology

Abstract:We have previously reported that nanoparticles (NPs) loaded with IL-2 and TGF-β and targeted to T cells induced polyclonal T regulatory cells (Tregs) that protected mice from graft-versus-host disease (GvHD). Here, we evaluated whether administration of these NPs during alloantigen immunization could prevent allograft rejection by converting immunogenic responses to tolerogenic ones. Using C57BL/6 mice and BALB/c mice as either donors or recipients of allogeneic splenocytes, we found that treatment with the tolerogenic NPs in both strains of mice resulted in a marked inhibition of mixed lymphocyte reaction (MLR) to donor cell alloantigen but not to third-party control mouse cells after transfer of the allogeneic cells. The decreased alloreactivity associated with a four- to fivefold increase in the number of CD4 + and CD8 + T regulatory cells (Tregs) and the acquisition of a tolerogenic phenotype by recipient dendritic cells (DCs) in NP-treated mice. As allogeneic cells persisted in NP-treated mice, these findings suggest that tolerogenic NPs can induce alloantigen-specific Tregs and tolerogenic DCs promoting tolerogenic responses to alloantigen. By inhibiting reactivity to allotransplant, this approach could help reduce the need for immune suppression for the maintenance of allografts.

immunology
Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance

Quanyu Chen,Zhiqing Yang,Heng Lin,Jiejuan Lai,Deyu Hu,Min Yan,Zhifang Wu,Wei Liu,Zhehai Li,Yu He,Zhe Sun,Ling Shuai,Zhiping Peng,Yangyang Wang,Sijin Li,Youhong Cui,Hongyu Zhang,Leida Zhang,Lianhua Bai

DOI: https://doi.org/10.3389/fimmu.2023.1162439

IF: 7.3

2023-08-09

Frontiers in Immunology

Abstract:Allostimulated CD8 + T cells (aCD8 + T cells), as the main mediators of acute liver rejection (ARJ), are hyposensitive to apoptosis due to the inactivation of death receptor FAS-mediated pathways and fail to allow tolerance induction, eventually leading to acute graft rejection. Although tacrolimus (FK506), the most commonly used immunosuppressant (IS) in the clinic, allows tolerance induction, its use is limited because its target immune cells are unknown and it is associated with increased incidences of malignancy, infection, and nephrotoxicity, which substantially impact long-term liver transplantation (LTx) outcomes. The dark agouti (DA)-to-Lewis rat LTx model is a well-known ARJ model and was hence chosen for the present study. We show that both hepatocyte growth factor (HGF) (cHGF, containing the main form of promoting HGF production) and recombinant HGF (h-rHGF) exert immunoregulatory effects mainly on allogeneic aCD8 + T cell suppression through FAS-mediated apoptotic pathways by inhibiting cMet to FAS antagonism and Fas trimerization, leading to acute tolerance induction. We also showed that such inhibition can be abrogated by treatment with neutralizing antibodies against cMet (HGF-only receptor). In contrast, we did not observe these effects in rats treated with FK506. However, we observed that the effect of anti-rejection by FK506 was mainly on allostimulated CD4 + T cell (aCD4 + T cell) suppression and regulatory T cell (Treg) promotion, in contrast to the mechanism of HGF. In addition, the protective mechanism of HGF in FK506-mediated nephrotoxicity was addressed. Therefore, HGF as a tolerance inducer, whether used in combination with FK506 or as monotherapy, may have good clinical value. Additional roles of these T-cell subpopulations in other biological systems and studies in these fields will also be meaningful.

immunology
[Disorders of position and movement of the eyeballs after the operation for retinal detachment].

K. Hruby

Klinika Oczna

Abstract:

Another case of pediatric cecal diverticulitis

Cue reactivity in nicotine and tobacco dependence: a “multiple-action” model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Fibroblastic reticular cells orchestrate long-term graft survival following recipient treatment with CD40 ligand-targeted costimulatory blockade

Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.

Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice

FRC transplantation restores lymph node conduit defects in laminin α4–deficient mice

Fibroblastic reticular cells provide a supportive niche for lymph node-resident macrophages

Helper T Cell (CD4 + ) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity

L-selectin-dependent Lymphoid Occupancy is Required to Induce Alloantigen-Specific Tolerance.

Human lymph node fibroblastic reticular cells maintain heterogeneous characteristics in culture

TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Metabolic Reprogramming of Fibroblastic Reticular Cells in Immunity and Tolerance

[Official systems of pharmacovigilance in France and in Spain. Comparison of spontaneous reporting in two regional centers: Pays Basque and Bordeaux].

Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.

Intragraft memory-like CD127hiCD4+Foxp3+ Tregs maintain transplant tolerance

Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen

Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance

[Disorders of position and movement of the eyeballs after the operation for retinal detachment].